US 11364251
Pharmaceutical formulation
granted A61KA61K31/573A61K31/58
Quick answer
US patent 11364251 (Pharmaceutical formulation) held by Semnur Pharmaceuticals, Inc. expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Semnur Pharmaceuticals, Inc.
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/573, A61K31/58, A61K31/661, A61K45/06